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In both segments, O-glycosylation of mucins was
strongly affected, with the appearance of elongated
polylactosaminic-chain containing O-glycan structures,
associated with flattening and loss of the mucus layer
cohesive properties specifically in the ileum. L. farci-
minis bound to intestinal Muc2 and prevented WAS-
induced functional alterations and changes in mucin
O-glycosylation and mucus physical properties.
Conclusion: WAS-induced functional changes were
associated with mucus alterations resulting from a
shift in O-glycosylation rather than from changes in
mucin expression. L. farciminis treatment prevented
these alterations, conferring epithelial and mucus bar-
rier strengthening.
Keywords: gut permeability, mucus layer, water
avoidance stress.
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Background: Oxidative stress plays a key role in the
development of intestinal inflammatory diseases. Sev-
eral pro-inflammatory mediators may generate oxida-
tion products that exacerbate the inflammatory
damage. Gastrointestinal molecules, like serotonin (5-
HT), adenosine and melatonin, which are involved in
intestinal physiology, have also been described as
intestinal pro-inflammatory factors; whereas IL-10, a
known anti-inflammatory cytokine, has also been
implicated in intestinal pathophysiology.
Aim: The aim of this study was to analyze the contri-
bution of pro-inflammatory and anti-inflammatory
molecules to oxidative stress balance, as well as to
assess their effect on cellular antioxidant enzymes
activity, in intestinal epithelial cells.
Methods: Caco-2 cells were treated with the different
molecules, and the oxidative stress was determined by
measuring lipid peroxidation (MDA+4HDA) and pro-
tein carbonyl levels. The activity of the anti-oxidant
enzymes (CAT), superoxide dismutase (SOD) and glu-
tathione peroxidase (GPx) was also analyzed in trea-
ted cells.
Results: Pro-inflammatory factors (5-HT, adenosine,
melatonin and TNFa) increased oxidative damage in
both lipids and proteins. Theses molecules, except
melatonin, also inhibited the activity of antioxidant
enzymes. With regard to IL-10, this cytokine was not
shown to alter cellular oxidative damage, but was able
to reduce the oxidative damage g by pro-inflamatory
factors, and to restore their effects on anti-oxidant
enxymes activities. Unexpectedly, IL-10, together with
melatonin, was found to increase the antioxidant
activity above the control.
Conclusions: The anti-oxidant effect of IL-10 empha-
sizes the role of this cytokine as a potential therapy
for the treatment of intestinal inflammation induced
by pro-inflammatory molecules.
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Background: DRA (Down Regulated in Adenoma) or
SLC26A3 is the major apical anion exchanger mediat-
ing Cl absorption in intestinal epithelial cells (IECs).
Reduction in DRA function and expression has been
implicated in diarrhea associated with inflammatory
bowel diseases (IBD). Upregulation of DRA, therefore,
appears to be a novel approach to treat IBD associ-
ated diarrhea. In this regard, ATRA, a key metabolite
of vitamin A is known to have anti-inflammatory and
immunomodulatory properties. We earlier showed
that ATRA, increased DRA function, expression and
promoter activity through RAR-b via the involvement
of transcription factor HNF-1b. Whether, ATRA
could modulate DRA function and expression under
inflammatory conditions is not known.
Aims: The aims were to evaluate the efficacy of
ATRA in attenuating the inhibitory effects of IFN-c
on DRA utilizing Caco-2 cells as an in vitro model
and Dextran sodium sulfate (DSS)-induced colitis as
an in vivo mouse model.
Methods: Caco-2 cells grown on filter inserts were
co-treated with IFN-c (30 ng/mL) and ATRA for
24 hr or DSS colitis (3% DSS in drinking water for
7 days) mice were co-treated with ATRA (1 mg/kg
body wt., i.p. for 7 days).
Results: Data demonstrated that ATRA abrogated IFN-
c induced decrease in DRA function as measured by
DIDS-sensitive 125I uptake. Parallel to this, IFN-c-
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